| 17-May-13 01:04PM | CYCLACEL PHARMACEUTICALS, INC. Financials EDGAR Online Financials |
| 16-May-13 04:46PM | Cyclacel Announces New Stock Issue at Motley Fool -13.54% |
| 10:12AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financia EDGAR Online |
| 09:01AM | InPlay: Cyclacel Pharma prices offering of 6,666,667 shares of its common stock at $3.00 per share Briefing.com |
| 09:00AM | Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering GlobeNewswire |
| 15-May-13 04:02PM | InPlay: Cyclacel Pharmaceuticals announces proposed public offering of common stock; number of shares not listed Briefing.com -6.47% |
| 04:01PM | Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire |
| 13-May-13 06:01PM | Cyclacel Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 04:01PM | Cyclacel Reports First Quarter 2013 Financial Results GlobeNewswire |
| 09:07AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online |
| 10-May-13 07:00AM | Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Results GlobeNewswire |
| 06-May-13 02:43PM | Cyclacel Pharmaceuticals' Convertible Exchangeable Preferred Stock Shares Cross 8% Yield Mark at Forbes |
| 30-Apr-13 07:55AM | Cyclacel Pharmaceuticals update Phase 2 survival data of sapacitabine for MDS theflyonthewall.com |
| 07:07AM | InPlay: Cyclacel Pharma reports updated Phase 2 survival data of sapacitabine for MDS; nearly doubles expected median survival of older patients with MDS who failed front-line therapies Briefing.com |
| 07:00AM | Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDS GlobeNewswire |
| 25-Apr-13 05:34PM | A Bullish Argument For Cyclacel's Sapacitabine And Seamless at Seeking Alpha |
| 23-Apr-13 07:00AM | Cyclacel Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference GlobeNewswire |
| 16-Apr-13 01:55PM | Reminder: Cyclacel Pharmaceuticals' 6% Preferred Stock Goes Ex-Dividend Soon at TheStreet |
| 09-Apr-13 02:24PM | InPlay: Cyclacel Pharma announces updated data from Phase 1 escalaction trial of sapacitabine and seliciclib at AACR Briefing.com |
| 02:20PM | Combination Potential of Cyclacel's Sapacitabine and Seliciclib Reported at AACR GlobeNewswire |
| 08-Apr-13 09:38AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 07:00AM | AACR Press Conference Highlights Combination Potential of Two Cyclacel Drugs GlobeNewswire |
| 05-Apr-13 06:09PM | Nasdaq stocks posting largest percentage decreases AP |
| 02:26PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:04PM | CYCLACEL PHARMACEUTICALS, INC. Financials EDGAR Online Financials |
| 04-Apr-13 08:06PM | Cyclacel Settles With Celgene, Sacrifices Small Gains For Bigger Interests at Seeking Alpha -6.67% |
| 06:03PM | Nasdaq stocks posting largest percentage decreases AP |
| 09:16AM | Cyclacel selling patents to Celgene for $5.5M AP |
| 07:01AM | InPlay: Cyclacel Pharma announces sale of four cyclacel romidepsin-related patents to Celgene (CELG) and dismissal of all claims in their patent litigation Briefing.com |
| 07:00AM | Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene and Dismissal of All Claims in Their Patent Litigation GlobeNewswire |
| 12:06AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 03-Apr-13 02:00PM | Cyclacel Announces Multiple Abstracts Selected for Presentation at American Association for Cancer Research Annual Meeting GlobeNewswire |
| 01-Apr-13 09:59AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online |
| 28-Mar-13 09:37AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 27-Mar-13 07:10PM | Cyclacel Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 04:01PM | Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results GlobeNewswire |
| 09:04AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online |
| 07:07AM | Q4 2012 Cyclacel Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN |
| 25-Mar-13 01:52PM | 5 Stocks Set to Soar on Bullish Earnings at TheStreet |
| 22-Mar-13 07:00AM | Cyclacel to Announce Year-End and Fourth Quarter 2012 Financial Results GlobeNewswire |
| 13-Mar-13 07:07AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 21-Feb-13 08:20AM | Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwire |
| 07:50AM | Cyclacel Pharma: Undervalued With Its Potential Blockbuster Drug at Seeking Alpha |
| 20-Feb-13 08:05AM | Upcoming Catalysts For These BioPharmas Provide Potential Upside at Seeking Alpha |
| 14-Feb-13 05:50AM | Celgene Corporation Vs. Cyclacel Pharmaceuticals, Inc.: The Markman Hearing And Its Likely Outcome at Seeking Alpha |
| 12-Feb-13 11:09AM | Questar Downgraded Due to Valuation and 3 Stock Analyses to Track at Wall St. Cheat Sheet |
| 07:06AM | InPlay: Cyclacel Pharma announces grants of new U.S. & European patents covering sapacitabine used in combination with HDAC inhibitors Briefing.com |
| 07:00AM | Cyclacel Announces Grants of New U.S. & European Patents Covering Sapacitabine Used in Combination With HDAC Inhibitors GlobeNewswire |
| 04-Feb-13 07:00AM | Cyclacel Pharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference GlobeNewswire |
| 01-Feb-13 05:19PM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 25-Jan-13 02:22PM | 4 Stocks Under $10 Moving Higher at TheStreet +9.14% |
| 08:20AM | Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash Marketwire |
| 24-Jan-13 01:23PM | Cyclacel Explained: Answers About The Long Misunderstood And Undervalued Biotech at Seeking Alpha |
| 18-Jan-13 03:09PM | Cyclacel Pharmaceuticals' Convertible Exchangeable Preferred Shares Cross 7% Yield Mark at Forbes |
| 17-Jan-13 04:26PM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 08-Jan-13 05:14AM | Looking Beyond The JPM Global Healthcare Conference: More Biotech Than Meets The Eye at Seeking Alpha |
| 07-Jan-13 12:06PM | 5 of Last Week's Biggest Losers at Motley Fool |
| 07:12AM | InPlay: Cyclacel Pharma reviews 2012 achievements and announces key business objectives for 2013; co expects to continue enrollment in SEAMLESS pivotal, Phase 3 study in 2013 Briefing.com |
| 07:00AM | Cyclacel Reviews 2012 Achievements and Announces Key Business Objectives for 2013 GlobeNewswire |
| 03-Jan-13 07:28AM | InPlay: Cyclacel Pharma: Tang Capital discloses 7.0% stake in 13G filing out last night Briefing.com |
| 02-Jan-13 06:02PM | Nasdaq stocks posting largest percentage decreases AP |
| 31-Dec-12 06:04PM | Nasdaq stocks posting largest percentage decreases AP |
| 05:02PM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 28-Dec-12 06:08PM | Nasdaq stocks posting largest percentage increases AP |
| 01:22PM | Nasdaq stocks posting largest percentage increases AP |
| 27-Dec-12 06:11PM | Nasdaq stocks posting largest percentage increases AP |
| 01:37PM | Nasdaq stocks posting largest percentage increases AP |
| 26-Dec-12 06:09PM | Nasdaq stocks posting largest percentage increases AP |
| 01:30PM | Nasdaq stocks posting largest percentage increases AP |
| 24-Dec-12 06:02PM | Nasdaq stocks posting largest percentage increases AP +9.81% |
| 01:23PM | Nasdaq stocks posting largest percentage increases AP |
| 18-Dec-12 03:27PM | 2012 Best Biotech and Health Care Executive Officer Interviews: the President and CEO of Cyclacel Pharmaceuticals, Inc. (CYCC) Wall Street Transcript |
| 17-Dec-12 07:34AM | InPlay from Briefing.com Briefing.com |
| 07:15AM | InPlay: Cyclacel Pharma enters into a $20 mln common stock purchase agreement with Aspire Capital Fund Briefing.com |
| 07:15AM | Cyclacel Enters Into a $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC GlobeNewswire |
| 07:11AM | CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of E EDGAR Online |
| 13-Dec-12 05:27PM | The Best of 2012 #7: Sunesis at Motley Fool |
| 10-Dec-12 05:16PM | Mondays big movers: Mr. Dimon goes to Washington at MarketWatch -5.89% |
| 03:31PM | Mondays big movers: Groupon takeover talk fizzles at MarketWatch |
| 01:58PM | Mondays big movers: Google rises despite outage at MarketWatch |
| 11:59AM | Mondays big movers: iPhone 5S likely June or July at MarketWatch |
| 08:18AM | Mondays biggest gaining and declining stocks at MarketWatch |
| 07:02AM | InPlay: Cyclacel Pharma presents updated survival data from the pilot study and lead-in phase of Seamless Phase 3 study; median overall survival is 238 days and 1-year survival is 35% with an overall response rate of 41% in elderly patients Briefing.com |
| 07:00AM | Cyclacel Presents Updated Survival Data From the Pilot Study and Lead-In Phase of Seamless Phase 3 Study at the 2012 ASH Annual Meeting GlobeNewswire |
| 09-Dec-12 10:16PM | Biotech Weekly Recap: The Market Holds While Biotech Crumbles at Seeking Alpha |
| 12:48PM | 5 of Last Week's Biggest Winners at Motley Fool |
| 07-Dec-12 06:05PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:21PM | Nasdaq stocks posting largest percentage decreases AP |
| 06-Dec-12 06:07PM | Nasdaq stocks posting largest percentage decreases AP -13.97% |
| 05-Dec-12 06:05PM | Nasdaq stocks posting largest percentage increases AP +19.15% |
| 01:27PM | Nasdaq stocks posting largest percentage increases AP |
| 04-Dec-12 09:46PM | Will Cyclacel Pharmaceuticals Pipeline Be a Success? at Wall St. Cheat Sheet |
| 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 04:02PM | Will Cyclacel Pharmaceuticals Pipeline Be a Success? at Wall St. Cheat Sheet |
| 01:25PM | Nasdaq stocks posting largest percentage increases AP |
| 09:00AM | Cyclacel to Report New Sapacitabine Clinical Data at the American Society of Hematology Annual Meeting GlobeNewswire |
| 08:32AM | Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases Marketwire |
| 08:20AM | Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases Marketwire |
| 08:05AM | 3 Small-Cap Biopharmas With Trade Catalysts And Speculation Investment Potential at Seeking Alpha |
| 07:40AM | High Risk High Reward Cyclacel Pharma Could Become A Long Term Multi-Bagger Thomson Reuters ONE |
